CA Patent

CA3020166A1 — Phosphaplatin liquid formulations

Assigned to PROMONTORY THERAPEUTICS INC. · Expires 2017-10-12 · 9y expired

What this patent protects

Pharmaceutical compositions of phosphaplatin compounds, in particular buffered stable liquid formulations of pyrodach-2 ready for use in the treatment of various cancers, and methods of preparation are disclosed.

USPTO Abstract

Pharmaceutical compositions of phosphaplatin compounds, in particular buffered stable liquid formulations of pyrodach-2 ready for use in the treatment of various cancers, and methods of preparation are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA3020166A1
Jurisdiction
CA
Classification
—
Expires
2017-10-12
Drug substance claim
No
Drug product claim
No
Assignee
PROMONTORY THERAPEUTICS INC.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.